{"id":"https://openalex.org/W4390988944","doi":"https://doi.org/10.1159/000535855","title":"Variations in Patterns of Prescribing Durvalumab in Stage III Lung Cancer: A Survey of Australian Medical Oncologists","display_name":"Variations in Patterns of Prescribing Durvalumab in Stage III Lung Cancer: A Survey of Australian Medical Oncologists","publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W4390988944","doi":"https://doi.org/10.1159/000535855","pmid":"https://pubmed.ncbi.nlm.nih.gov/38232722"},"language":"en","primary_location":{"id":"doi:10.1159/000535855","doi":"https://doi.org/10.1159/000535855","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000535855","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071552439","display_name":"Udit Nindra","orcid":"https://orcid.org/0000-0002-2612-9502","observed_orcids":["https://orcid.org/0000-0002-2612-9502"]},"institutions":[{"id":"https://openalex.org/I2800849109","display_name":"Liverpool Hospital","ror":"https://ror.org/03zzzks34","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800849109"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Udit Nindra","raw_affiliation_strings":["Department of Medical Oncology, Liverpool Hospital, Liverpool, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Liverpool Hospital, Liverpool, New South Wales, Australia","institution_ids":["https://openalex.org/I2800849109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024052979","display_name":"Victoria Bray","orcid":"https://orcid.org/0000-0002-6357-3899","observed_orcids":["https://orcid.org/0000-0002-6357-3899"]},"institutions":[{"id":"https://openalex.org/I2800849109","display_name":"Liverpool Hospital","ror":"https://ror.org/03zzzks34","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800849109"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Victoria Bray","raw_affiliation_strings":["Department of Medical Oncology, Liverpool Hospital, Liverpool, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Liverpool Hospital, Liverpool, New South Wales, Australia","institution_ids":["https://openalex.org/I2800849109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080064170","display_name":"Deme John Karikios","orcid":"https://orcid.org/0000-0003-1734-9615","observed_orcids":["https://orcid.org/0000-0003-1734-9615"]},"institutions":[{"id":"https://openalex.org/I2801688508","display_name":"Nepean Hospital","ror":"https://ror.org/03vb6df93","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801688508"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Deme Karikios","raw_affiliation_strings":["Department of Medical Oncology, Nepean Hospital, Nepean, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Nepean Hospital, Nepean, New South Wales, Australia","institution_ids":["https://openalex.org/I2801688508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000893223","display_name":"Mohsen Shafiei","orcid":"https://orcid.org/0000-0002-6208-2000","observed_orcids":["https://orcid.org/0000-0002-6208-2000"]},"institutions":[{"id":"https://openalex.org/I2800681009","display_name":"Bankstown Lidcombe Hospital","ror":"https://ror.org/00qrpt643","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1311436738","https://openalex.org/I2800681009","https://openalex.org/I2801351115","https://openalex.org/I4210163551"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Mohsen Shafiei","raw_affiliation_strings":["Department of Medical Oncology, Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia","institution_ids":["https://openalex.org/I2800681009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066274807","display_name":"Shalini Subramaniam","orcid":"https://orcid.org/0000-0003-2138-8633","observed_orcids":["https://orcid.org/0000-0003-2138-8633"]},"institutions":[{"id":"https://openalex.org/I2800681009","display_name":"Bankstown Lidcombe Hospital","ror":"https://ror.org/00qrpt643","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1311436738","https://openalex.org/I2800681009","https://openalex.org/I2801351115","https://openalex.org/I4210163551"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Shalini Subramaniam","raw_affiliation_strings":["Department of Medical Oncology, Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia","institution_ids":["https://openalex.org/I2800681009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102964792","display_name":"Pei N. Ding","orcid":"https://orcid.org/0000-0002-0116-2381","observed_orcids":["https://orcid.org/0000-0002-0116-2381"]},"institutions":[{"id":"https://openalex.org/I2801688508","display_name":"Nepean Hospital","ror":"https://ror.org/03vb6df93","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801688508"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Pei Ding","raw_affiliation_strings":["Department of Medical Oncology, Nepean Hospital, Nepean, New South Wales, Australia","Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Nepean Hospital, Nepean, New South Wales, Australia","institution_ids":["https://openalex.org/I2801688508"]},{"raw_affiliation_string":"Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia","institution_ids":["https://openalex.org/I2803024705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110209017","display_name":"Steven Chuan-Hao Kao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Kao","raw_affiliation_strings":["Department of Medical Oncology, Sydney, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Sydney, New South Wales, Australia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088121271","display_name":"Abhijit Pal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800681009","display_name":"Bankstown Lidcombe Hospital","ror":"https://ror.org/00qrpt643","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1311436738","https://openalex.org/I2800681009","https://openalex.org/I2801351115","https://openalex.org/I4210163551"]},{"id":"https://openalex.org/I2800849109","display_name":"Liverpool Hospital","ror":"https://ror.org/03zzzks34","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800849109"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Abhijit Pal","raw_affiliation_strings":["Department of Medical Oncology, Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia","Department of Medical Oncology, Liverpool Hospital, Liverpool, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia","institution_ids":["https://openalex.org/I2800681009"]},{"raw_affiliation_string":"Department of Medical Oncology, Liverpool Hospital, Liverpool, New South Wales, Australia","institution_ids":["https://openalex.org/I2800849109"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5071552439"],"corresponding_institution_ids":["https://openalex.org/I2800849109"],"apc_list":null,"apc_paid":null,"fwci":0.7757,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.6780555,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":96},"biblio":{"volume":"102","issue":"8","first_page":"732","last_page":"736"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.4745999872684479,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.4745999872684479,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.2849000096321106,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.210099995136261,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/stage-iii-non-small-cell-lung-cancer","display_name":"stage III NSCLC","score":0.9240000247955322},{"id":"https://openalex.org/keywords/inoperable-lung-cancer","display_name":"inoperable lung cancer","score":0.902999997138977},{"id":"https://openalex.org/keywords/consolidation-immunotherapy","display_name":"consolidation immunotherapy","score":0.8610000014305115},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.8799999952316284},{"id":"https://openalex.org/keywords/medical-oncologists","display_name":"medical oncologists","score":0.5889999866485596},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.7870000004768372},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.8759999871253967},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.953000009059906}],"concepts":[{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.9430732727050781},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8066976070404053},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5645437240600586},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.5614641904830933},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5192582607269287},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5089936256408691},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4099862575531006},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.1839544177055359},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.1066502034664154},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000072103","descriptor_name":"Oncologists","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001315","descriptor_name":"Australia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009520","descriptor_name":"New Zealand","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000535855","doi":"https://doi.org/10.1159/000535855","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000535855","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},{"id":"pmid:38232722","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38232722","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"News"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W2753065806","https://openalex.org/W2770828094","https://openalex.org/W2921475903","https://openalex.org/W3010768695","https://openalex.org/W3022263550","https://openalex.org/W3033809288","https://openalex.org/W3109266756","https://openalex.org/W3131416308","https://openalex.org/W3172131160","https://openalex.org/W3192994113","https://openalex.org/W3203228606","https://openalex.org/W4200347883","https://openalex.org/W4286293755","https://openalex.org/W4310256687","https://openalex.org/W4321793655","https://openalex.org/W4322618197","https://openalex.org/W4385650158"],"related_works":["https://openalex.org/W7138461902","https://openalex.org/W3216085279","https://openalex.org/W2909427482","https://openalex.org/W2981384287","https://openalex.org/W3107501938","https://openalex.org/W3165874405","https://openalex.org/W4322618197","https://openalex.org/W3127505349","https://openalex.org/W2989982365","https://openalex.org/W4281678326"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Local":[1,248],"Australian":[2,230],"guidelines":[3,26,250],"for":[4,30,141,167,185,221,266],"the":[5,91,111,123,226,243],"optimal":[6],"management":[7],"of":[8,22,39,50,82,95,115,134,156,181,200,229,271],"stage":[9,35,99,129,176],"III":[10,36,100,130,177],"unresectable":[11,34,101,131,178],"non-small":[12],"cell":[13],"lung":[14],"cancer":[15,88],"(NSCLC)":[16],"are":[17,251],"lacking.":[18],"The":[19,47],"American":[20],"Society":[21,49],"Clinical":[23],"Oncology":[24,52,113],"(ASCO)":[25],"recommend":[27],"consolidation":[28,56,157,222],"durvalumab":[29,57,97,140,158,184],"all":[31,142,186],"patients":[32,62,126,171,210],"with":[33,55,127,162,172,211,241],"NSCLC,":[37,132,179],"irrespective":[38],"their":[40],"PD-L1":[41,173],"expression":[42],"or":[43,214,245],"driver":[44],"mutation":[45],"status.":[46],"European":[48],"Medical":[51,234],"(ESMO)":[53],"differs,":[54],"only":[58],"recommended":[59,149,193],"in":[60,86,93,98,159,209,256],"those":[61],"whose":[63],"tumours":[64],"express":[65],"PD-L1.":[66],"METHODS:":[67],"Due":[68],"to":[69,89,253],"differing":[70],"global":[71],"guidelines,":[72],"we":[73],"conducted":[74],"an":[75,145,163,189],"Australia":[76,116],"and":[77,108,198,231],"New":[78,232],"Zealand":[79,233],"wide":[80],"survey":[81,104],"medical":[83,120],"oncologists":[84,121],"specialising":[85],"thoracic":[87],"determine":[90],"variations":[92],"patterns":[94,258],"prescribing":[96,257],"NSCLC.":[102],"This":[103],"was":[105],"done":[106],"electronically":[107],"sponsored":[109],"by":[110],"Thoracic":[112],"Group":[114],"(TOGA).":[117],"RESULTS:":[118],"Thirty-two":[119],"completed":[122],"survey.":[124],"In":[125,170],"EGFR-mutated":[128],"6%":[133,147],"respondents":[135,182],"stated":[136],"that":[137],"they":[138],"prescribed":[139,183],"patients,":[143,187],"while":[144,188],"additional":[146,164,190],"strongly":[148,192],"treatment.":[150,194],"Forty-four":[151],"percent":[152],"suggested":[153],"little":[154],"benefit":[155],"this":[160],"cohort,":[161],"19%":[165],"advocating":[166],"observation":[168],"only.":[169],"negative":[174],"(0%)":[175],"13%":[180],"56%":[191],"Interestingly,":[195],"18%,":[196],"10%,":[197],"10%":[199],"prescribers":[201],"discussed":[202],"self-funded":[203,267],"oral":[204],"tyrosine":[205],"kinase":[206],"inhibitor":[207],"therapy":[208],"EGFR,":[212],"ALK,":[213],"ROS-1-mutated":[215],"NSCLC":[216],"respectively":[217],"as":[218,261,263],"a":[219],"substitute":[220],"durvalumab.":[223],"CONCLUSION:":[224],"Overall,":[225],"clinical":[227],"practice":[228,249],"Oncologists":[235],"is":[236],"variable,":[237],"but":[238],"remains":[239],"consistent":[240],"either":[242],"ASCO":[244],"ESMO":[246],"guidelines.":[247],"required":[252],"ensure":[254],"consistency":[255],"across":[259],"Australia,":[260],"well":[262],"providing":[264],"evidence":[265],"treatments":[268],"outside":[269],"standard":[270],"care.":[272]},"counts_by_year":[{"year":2025,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-01-19T00:00:00"}